205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.98%
Revenue growth above 1.5x AMD's 2.71%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.85%
Gross profit growth at 75-90% of AMD's 17.84%. Bill Ackman would demand operational improvements to match competitor gains.
55.96%
EBIT growth 50-75% of AMD's 84.38%. Martin Whitman would suspect suboptimal resource allocation.
34.61%
Operating income growth under 50% of AMD's 84.38%. Michael Burry would be concerned about deeper cost or sales issues.
52.80%
Net income growth under 50% of AMD's 164.97%. Michael Burry would suspect the firm is falling well behind a key competitor.
58.33%
EPS growth under 50% of AMD's 175.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
58.33%
Diluted EPS growth under 50% of AMD's 175.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-4.00%
Share reduction while AMD is at 0.59%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-3.80%
Reduced diluted shares while AMD is at 3.22%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.68%
Dividend reduction while AMD stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
58.13%
OCF growth above 1.5x AMD's 5.51%. David Dodd would confirm a clear edge in underlying cash generation.
131.71%
FCF growth above 1.5x AMD's 85.74%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-8.26%
Negative 10Y revenue/share CAGR while AMD stands at 9.06%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
19.49%
Positive 5Y CAGR while AMD is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
74.31%
3Y revenue/share CAGR similar to AMD's 81.41%. Walter Schloss would assume both companies experience comparable short-term cycles.
93.48%
Positive long-term OCF/share growth while AMD is negative. John Neff would see a structural advantage in sustained cash generation.
35.53%
Positive OCF/share growth while AMD is negative. John Neff might see a comparative advantage in operational cash viability.
148.63%
3Y OCF/share CAGR under 50% of AMD's 312.69%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
107.17%
Positive 10Y CAGR while AMD is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-49.18%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
669.14%
3Y net income/share CAGR above 1.5x AMD's 105.29%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
195.47%
Positive growth while AMD is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
-5.11%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
17.24%
Positive short-term equity growth while AMD is negative. John Neff sees a strong advantage in near-term net worth buildup.
63.48%
Stable or rising dividend while AMD is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
26.48%
Dividend/share CAGR of 26.48% while AMD is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
9.16%
3Y dividend/share CAGR of 9.16% while AMD is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
12.15%
AR growth well above AMD's 5.35%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.45%
Inventory is declining while AMD stands at 7.68%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.72%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.31%
Positive BV/share change while AMD is negative. John Neff sees a clear edge over a competitor losing equity.
-3.22%
We’re deleveraging while AMD stands at 1.40%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.40%
Our R&D shrinks while AMD invests at 7.69%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.45%
We cut SG&A while AMD invests at 7.93%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.